On ECHEMI
Home > Drugs > Chongqing Qingyang Pharmaceutical Co., Ltd.
Chongqing Qingyang Pharmaceutical Co., Ltd.
  • Founded in:

    2002-05-21
  • Country:

    China China
  • Address:

    Room 7-1, Building 1, No. 2, Gang'an 2nd Road, Jiangbei District, Chongqing
  • Tax NO.:

    915001057365937855
  • Registered Funds:

    100.764 million yuan
  • Website:

  • Email:

Related Drugs
Bifonazole
Name Description Content CAS NO. Registered Holders
Bifonazole

Extract from the above information

More

Extract from the above information

60628-96-8 11
Cimetidine
Cimetidine. Its chemical name is: N-methyl-N-[2[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]-N-cyanoguanidine. Molecular formula: C10H16N6S Molecular weight: 252.34
Name Description Content CAS NO. Registered Holders
Cimetidine

It mainly acts on H2 receptors on parietal cells, competitively inhibiting histamine. It can inhibit basal gastric acid secretion, as well as gastric acid secretion stimulated by food, histamine, pentagastrin, caffeine and insulin.

More

It mainly acts on H2 receptors on parietal cells, competitively inhibiting histamine. It can inhibit basal gastric acid secretion, as well as gastric acid secretion stimulated by food, histamine, pentagastrin, caffeine and insulin.

51481-61-9 35
Dipyridamole
Name Description Content CAS NO. Registered Holders
Dipyridamole

Extract from the above information

More

Extract from the above information

58-32-2 36
Ranitidine hydrochloride
Name Description Content CAS NO. Registered Holders
Ranitidine Hydrochloride

Inhibit gastric acid secretion

More

Inhibit gastric acid secretion

66357-59-3 48
Allopurinol
The main ingredient of this product is allopurinol, whose chemical name is 1H-pyrazolo[3,4-d]pyrimidine-4-ol.
Name Description Content CAS NO. Registered Holders
Allopurinol

This product is a drug that inhibits the synthesis of uric acid. Allopurinol and its metabolite oxypurinol can inhibit xanthine oxidase, preventing hypoxanthine and xanthine from being metabolized into uric acid, thereby reducing the production of uric acid. It reduces the uric acid content in the blood and urine to a level below the solubility, prevents uric acid from forming crystals and depositing in joints and other tissues, and also helps to redissolve uric acid crystals in the tissues of gout patients. Allopurinol also inhibits the synthesis of new purines in the body by acting on hypoxanthine-guanine phosphate nucleic acid convertase.

More

This product is a drug that inhibits the synthesis of uric acid. Allopurinol and its metabolite oxypurinol can inhibit xanthine oxidase, preventing hypoxanthine and xanthine from being metabolized into uric acid, thereby reducing the production of uric acid. It reduces the uric acid content in the blood and urine to a level below the solubility, prevents uric acid from forming crystals and depositing in joints and other tissues, and also helps to redissolve uric acid crystals in the tissues of gout patients. Allopurinol also inhibits the synthesis of new purines in the body by acting on hypoxanthine-guanine phosphate nucleic acid convertase.

315-30-0 64
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.